| Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin lymphoma MGM Roemer, RA Redd, FZ Cader, CJ Pak, S Abdelrahman, J Ouyang, ... Journal of Clinical Oncology 36 (10), 942-950, 2018 | 338 | 2018 |
| Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status MGM Roemer, RH Advani, RA Redd, GS Pinkus, Y Natkunam, AH Ligon, ... Cancer immunology research 4 (11), 910-916, 2016 | 200 | 2016 |
| Relapsed or refractory double-expressor and double-hit lymphomas have inferior progression-free survival after autologous stem-cell transplantation AF Herrera, M Mei, L Low, HT Kim, GK Griffin, JY Song, RW Merryman, ... Journal of Clinical Oncology 35 (1), 24-31, 2017 | 189 | 2017 |
| Angiopoietin-2 as a biomarker and target for immune checkpoint therapy X Wu, A Giobbie-Hurder, X Liao, C Connelly, EM Connolly, J Li, ... Cancer immunology research 5 (1), 17-28, 2017 | 149 | 2017 |
| Genetic basis for PD-L1 expression in squamous cell carcinomas of the cervix and vulva BE Howitt, HH Sun, MGM Roemer, A Kelley, B Chapuy, E Aviki, C Pak, ... JAMA oncology 2 (4), 518-522, 2016 | 133 | 2016 |
| Ethanol extract of Bupleurum falcatum and saikosaponins inhibit neuroinflammation via inhibition of NF-κB WH Park, S Kang, Y Piao, CJ Pak, MS Oh, J Kim, MS Kang, YK Pak Journal of ethnopharmacology 174, 37-44, 2015 | 68 | 2015 |
| Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma N Jain, K Hartert, S Tadros, W Fiskus, O Havranek, MCJ Ma, A Bouska, ... Science translational medicine 11 (497), eaav5599, 2019 | 58 | 2019 |
| Outcomes after allogeneic stem cell transplantation in patients with double-hit and double-expressor lymphoma AF Herrera, SJ Rodig, JY Song, Y Kim, GK Griffin, D Yang, L Nikolaenko, ... Biology of Blood and Marrow Transplantation 24 (3), 514-520, 2018 | 44 | 2018 |
| Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma GK Griffin, JL Weirather, MGM Roemer, M Lipschitz, A Kelley, PH Chen, ... Blood, The Journal of the American Society of Hematology 137 (10), 1353-1364, 2021 | 40 | 2021 |
| Double-hit and double-expressor lymphomas are not associated with an adverse outcome after allogeneic stem cell transplantation AF Herrera, JY Song, GK Griffin, L Nikolaenko, M Mei, V Bedell, P Dal Cin, ... Blood, The Journal of the American Society of Hematology 128 (22), 830-830, 2016 | 4 | 2016 |
| Expression of major histocompatibility complex (MHC) class II, but not MHC class I, predicts outcome in patients with classical Hodgkin lymphoma (cHL) treated with nivolumab … MGM Roemer, RA Redd, FZ Cader, CJ Pak, S Abdelrahman, J Ouyang, ... Blood 130, 1450, 2017 | 3 | 2017 |
| Integrated genetic and topological analysis reveals a Hodgkin-like mechanism of immune escape in T-cell/histiocyte-rich large B-cell lymphoma GK Griffin, MGM Roemer, M Lipschitz, J Weirather, CJ Pak, A Kelly, ... Blood 132, 1579, 2018 | 2 | 2018 |
| N-and C-terminal non-conserved residues contribute to transactivation by a sea anemone (Nematostella vectensis) NF-κB transcription factor A Alshanbayeva, A Thomas, M Tremblay, M Abbas, F Abdurrob, T Almojel, ... Bios 86 (4), 165-175, 2015 | 2 | 2015 |
| DNA copy number gains of TCF4 (E2-2) are associated with poor outcome in diffuse large B-cell lymphoma K Hartert, S Tadros, A Bouska, D Moore, C Pak, T Heavican, CL Liu, ... Blood 128 (22), 2686, 2016 | 1 | 2016 |
| DNA copy number gains of TCF4 (E2-2) are associated with poor outcome and the activated B-cell-like subtype of diffuse large B-cell lymphoma K Hartert, S Tadros, A Bouska, D Moore, T Heavican, C Pak, CL Liu, ... bioRxiv, 170605, 2017 | | 2017 |
| Recurrent gains of CD274 (PD-L1) and PDCD1LG2 (PD-L2) provide a genetic basis for PD-1 ligand expression in a subset of solid tumors E Gjini, C Pak, A Kelly, Y Shi, N Lindeman, F Kuo, G Freeman, A Ligon, ... Cancer Research 76 (14_Supplement), 4027-4027, 2016 | | 2016 |
| Recurrent Gains of CD274 and PDCD1LG2 in Squamous Cell Carcinomas of Cervix and Vulva BE Howitt, H Sun, MGM Roemer, A Kelly, B Chapuy, EM Aviki, C Pak, ... LABORATORY INVESTIGATION 96, 287A-288A, 2016 | | 2016 |
| Copy Number Gain of PD-L1 and PD-L2 in T-Cell/Histiocyte Rich Large B-Cell Lymphoma GK Griffin, SB Lovitch, A Kelley, MGM Roemer, B Chapuy, C Pak, E Gjini, ... LABORATORY INVESTIGATION 96, 348A-348A, 2016 | | 2016 |
| Inhibitory Effects of Gleditsia sinensis fruit extract on telomerase activity and oncognegic expression in human esophageal squamous cell carcinoma. C Pak, CO Kai, F Johnny, HC Sarwat, HL Chung, KT Stanton, L Wing, ... | | 2007 |
